-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On July 30, the official website of NMPA released the approval document, and Borui Medicine's oseltamivir phosphate capsule was approved for marketing, becoming the first approved generic drug in China
From: NMPA official website
Oseltamivir (Oseltamivir) is a specific inhibitor that acts on neuraminidase, which can inhibit the mature influenza virus from detaching from the host cell, thereby inhibiting the spread of influenza virus in the human body to play a role in the treatment of influenza
The original manufacturer of oseltamivir is Roche, and its trade name is Tamiflu.
Currently, according to the Insight database, Dongyang Sunshine has two dosage forms of oseltamivir capsules and granules, and has also submitted an application for the marketing of oseltamivir dry suspension, which is currently under review and approval; at the same time, it has also applied for sustained-release tablets.
According to the 2020 financial report of Dongyang Pharmaceutical, the sales of Kewei granules and capsules totaled 2.
From the Insight database (http://db.
However, the current granular formulation is Dongyang Sun's exclusive formulation, and only Dongyang Sunshine has obtained production approval, and the patent protection period is until 2026
From the Insight database (http://db.
